BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18090676)

  • 1. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME; Dunlap ME
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):87-92. PubMed ID: 18090676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
    Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal adaptation to the failing heart. Understanding the cascade of responses.
    Riley DJ; Weir M; Bakris GL
    Postgrad Med; 1994 Jun; 95(8):141-6, 149-50. PubMed ID: 8202419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current concepts of neurohormonal activation in heart failure: mediators and mechanisms.
    Lee CS; Tkacs NC
    AACN Adv Crit Care; 2008; 19(4):364-85; quiz 386-7. PubMed ID: 18981739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of renal function in heart failure.
    Makaritsis KP; Liakopoulos V; Leivaditis K; Eleftheriadis T; Stefanidis I
    Ren Fail; 2006; 28(7):527-35. PubMed ID: 17050233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of renal retention of sodium and water in heart failure, cirrhosis and pregnancy].
    Knotek M; Rogachev B; Ohara M; Schrier RW
    Lijec Vjesn; 2000; 122(1-2):20-6. PubMed ID: 10916353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurohormonal factors in heart failure. I].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 Apr; 49(4):239-52. PubMed ID: 8650399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and therapy of heart failure, new insights and developments. Part II. Cardiac and peripheral alterations during progressive heart failure.
    Remme WJ
    Neth J Med; 1993 Oct; 43(3-4):125-46. PubMed ID: 8302392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium and water retention in heart failure: pathogenesis and treatment.
    Martin PY; Schrier RW
    Kidney Int Suppl; 1997 Jun; 59():S57-61. PubMed ID: 9185106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurohormonal activity in heart insufficiency].
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Ugeskr Laeger; 1993 Jun; 155(23):1784-8. PubMed ID: 8317027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathology of heart failure].
    Gomes MC; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II7-23. PubMed ID: 15222247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure.
    Kazory A
    Am J Cardiol; 2010 Sep; 106(5):694-700. PubMed ID: 20723648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of volume overload in acute heart failure syndromes.
    Chen HH; Schrier RW
    Am J Med; 2006 Dec; 119(12 Suppl 1):S11-6. PubMed ID: 17113395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac afferents and neurohormonal activation in congestive heart failure.
    Davila DF; Donis JH; Bellabarba G; Torres A; Casado J; Mazzei de Davila C
    Med Hypotheses; 2000 Feb; 54(2):242-53. PubMed ID: 10790760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.